INMED PHARMACEUTICALS is trading at 4.14 as of the 24th of December 2024. This is a 15.34 percent decrease since the beginning of the trading day. The stock's lowest day price was 4.14. INMED PHARMACEUTICALS has 50 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. INMED PHARMACEUTICALS has reported 20 for 1 split on 15th of November 2024. The performance scores are derived for the period starting the 4th of January 2023 and ending today, the 24th of December 2024. Click here to learn more.
Although INMED PHARMACEUTICALS's alpha and beta are two of the key measurements used to evaluate INMED PHARMACEUTICALS's performance over the market, the standard measures of volatility play an important role as well.
The output start index for this execution was zero with a total number of output elements of sixty-one. INMED PHARMACEUTICALS INC Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe INMED PHARMACEUTICALS price patterns.
Our tools can tell you how much better you can do entering a position in INMED PHARMACEUTICALS without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Sign In To Macroaxis Now
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
INMED PHARMACEUTICALS financial ratios help investors to determine whether INMED Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in INMED with respect to the benefits of owning INMED PHARMACEUTICALS security.